ArticleTheranostics2017

Obatoclax and LY3009120 Efficiently Overcome Vemurafenib Resistance in Differentiated Thyroid Cancer.

Wei-Jun Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.